MediXall (MDXL) Equity Average (2019 - 2024)
MediXall's Equity Average history spans 6 years, with the latest figure at -$5.6 million for Q3 2024.
- For Q3 2024, Equity Average fell 10.19% year-over-year to -$5.6 million; the TTM value through Sep 2024 reached -$5.6 million, down 10.19%, while the annual FY2023 figure was -$5.1 million, 154.22% down from the prior year.
- Equity Average reached -$5.6 million in Q3 2024 per MDXL's latest filing, up from -$7.3 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $699191.0 in Q1 2021 to a low of -$7.3 million in Q2 2024.
- Average Equity Average over 5 years is -$2.3 million, with a median of -$1.2 million recorded in 2022.
- Peak YoY movement for Equity Average: surged 296.44% in 2020, then crashed 2590.6% in 2022.
- A 5-year view of Equity Average shows it stood at $557907.0 in 2020, then tumbled by 121.94% to -$122382.5 in 2021, then plummeted by 2590.6% to -$3.3 million in 2022, then crashed by 78.76% to -$5.9 million in 2023, then increased by 5.59% to -$5.6 million in 2024.
- Per Business Quant, the three most recent readings for MDXL's Equity Average are -$5.6 million (Q3 2024), -$7.3 million (Q2 2024), and -$6.8 million (Q1 2024).